Symbol="RYTM"
AssetType="Common Stock"
Name="Rhythm Pharmaceuticals Inc"
Description="Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of rare genetic diseases of obesity. The company is headquartered in Boston, Massachusetts."
CIK="1649904"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="932420000"
EBITDA="-177218000"
PERatio="None"
PEGRatio="None"
BookValue="3.865"
DividendPerShare="0"
DividendYield="0"
EPS="-3.16"
RevenuePerShareTTM="0.626"
ProfitMargin="0"
OperatingMarginTTM="-5.33"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-0.793"
RevenueTTM="33609000"
GrossProfitTTM="21505000"
DilutedEPSTTM="-3.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.66"
AnalystTargetPrice="37.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="95.69"
PriceToBookRatio="5.01"
EVToRevenue="63.85"
EVToEBITDA="-3.718"
Beta="1.684"
num_52WeekHigh="34.99"
num_52WeekLow="10.08"
num_50DayMovingAverage="17.2"
num_200DayMovingAverage="22.73"
SharesOutstanding="56855000"
DividendDate="None"
ExDividendDate="None"
symbol="RYTM"
open="16.53"
high="16.80"
low="15.77"
price="16.05"
volume="486293.00"
latest_trading_day="2023-07-13"
previous_close="16.40"
change="-0.35"
change_percent="-2.1341%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="96"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="4"
Volume_recent_avg="722126"
Change_recent_avg="-0.07"
Delta_recent_avg="1.05"
Variance_recent_avg="0.53"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="4"
Aroon_momentum_negative="96"
image_negative_thumbnail_id_1="113"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_negative_thumbnail_id_2="168"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0008.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="1166"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_positive_thumbnail_id_2="634"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0074.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
